GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (FRA:II2) » Definitions » Shiller PE Ratio

InspireMD (FRA:II2) Shiller PE Ratio : (As of May. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is InspireMD Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


InspireMD Shiller PE Ratio Historical Data

The historical data trend for InspireMD's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InspireMD Shiller PE Ratio Chart

InspireMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

InspireMD Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InspireMD's Shiller PE Ratio

For the Medical Devices subindustry, InspireMD's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InspireMD's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where InspireMD's Shiller PE Ratio falls into.



InspireMD Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

InspireMD's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, InspireMD's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.119/129.4194*129.4194
=-0.119

Current CPI (Dec. 2023) = 129.4194.

InspireMD Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -862,972.800 99.695 -1,120,276.665
201406 -1,113,126.400 100.560 -1,432,586.188
201409 -1,051,480.000 100.428 -1,355,022.322
201412 -647,448.063 99.070 -845,791.800
201503 -437,807.832 99.621 -568,763.314
201506 -314,117.595 100.684 -403,767.739
201509 -294,921.000 100.392 -380,196.519
201512 -238,179.690 99.792 -308,891.985
201603 -126,393.500 100.470 -162,811.842
201606 -108,246.250 101.688 -137,766.019
201609 -34,853.782 101.861 -44,283.441
201612 -38,394.000 101.863 -48,780.647
201703 -11,478.901 102.862 -14,442.550
201706 -7,188.939 103.349 -9,002.383
201709 -6,162.514 104.136 -7,658.753
201712 -2,331.228 104.011 -2,900.711
201803 -656.907 105.290 -807.455
201806 -98.354 106.317 -119.726
201809 -31.752 106.507 -38.583
201812 -32.962 105.998 -40.245
201903 -50.710 107.251 -61.192
201906 -21.107 108.070 -25.277
201909 -17.161 108.329 -20.502
201912 -7.695 108.420 -9.185
202003 -5.813 108.902 -6.908
202006 -2.602 108.767 -3.096
202009 -0.815 109.815 -0.960
202012 -1.233 109.897 -1.452
202103 -0.445 111.754 -0.515
202106 -0.382 114.631 -0.431
202109 -0.451 115.734 -0.504
202112 -0.469 117.630 -0.516
202203 -0.518 121.301 -0.553
202206 -0.558 125.017 -0.578
202209 -0.586 125.227 -0.606
202212 -0.566 125.222 -0.585
202303 -0.495 127.348 -0.503
202306 -0.222 128.729 -0.223
202309 -0.141 129.860 -0.141
202312 -0.119 129.419 -0.119

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InspireMD  (FRA:II2) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


InspireMD Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of InspireMD's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


InspireMD (FRA:II2) Business Description

Traded in Other Exchanges
Address
4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

InspireMD (FRA:II2) Headlines

No Headlines